Eli Lilly and Company vs Royal Bank of Canada
Eli Lilly and Company is worth $1.061T, 3.7× the $287.952B market cap of Royal Bank of Canada. Updated daily.
| Metric | ||
|---|---|---|
| Market cap | $1.061T | $287.952B |
| Global rank | #1 | #2 |
| Share price | $1,189.41 | $207.21 |
| Change | -2.11% | -1.45% |
| Revenue | $65.179B | $46.873B |
| Net income | $20.640B | $14.345B |
| Country | United States | Canada |
| Sector | Healthcare | Financial Services |
Want a wider comparison? Compare up to five companies.
Related comparisons
Frequently asked questions
- Is Eli Lilly and Company bigger than Royal Bank of Canada?
- Eli Lilly and Company has a market cap of $1.061T against $287.952B for Royal Bank of Canada, making it 3.7 times as valuable.
- Which company earns more, LLY or RY?
- Eli Lilly and Company reported net income of $20.640B and Royal Bank of Canada reported $14.345B in their most recent annual periods.